Lincoln Pharmaceuticals informs about disclosure

16 Aug 2021 Evaluate

Lincoln Pharmaceuticals has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanbhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

480.00 -3.20 (-0.66%)
01-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.50
Dr. Reddys Lab 1252.10
Cipla 1500.45
Zydus Lifesciences 907.95
Lupin 2092.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×